Insomnia Market Research Report 2019-2023 Targated Regions are Europe, The Middle East And Africa
Market Scenario:
Insomnia a sleeping disorder caused by unhealthy sleep
habits of a person. Medical conditions that may lead to insomnia are chronic
pain, neurological conditions (Parkinson's disease), arthritis, nasal/sinus
allergies, gastrointestinal problems, low back pain endocrine problems, asthma
and other conditions. It is found to be prevalent among women than in men which
may be the results of stress. The Increasing incidence of neurological
disorders like Parkinson’s disease favor the growth of this market. The market
of insomnia in Europe, the Middle East and Africa is increasing due to
increasing insomnia owing to lifestyle changes and use of sleeping pill. Mental
stress related to work or other personal issues is found to be another cause
leading to insomnia thus favouring the growth of market. Over consumption of
sleeping pills may be fatal for the person requiring critical care. Increased
psychological and emotional stress is also found to be a major cause of
insomnia. Europe, the Middle East and Africa insomnia market is expected to
grow at a CAGR of 4.28% during forecasted period of 2017-2023.
Segmentation :
Europe, the Middle East and Africa insomnia market has been
segmented on the basis of types of therapy which comprises pharmacological
therapy and non-pharmacological therapy. Pharmacological therapy is further
segmented into benzodiazepines, non-benzodiazepines, melatonin receptor
agonists and other. Non pharmacological treatment are further segmented into
relaxation therapy, cognitive behavioural therapy, sleep hygiene education,
stimulus control, paradoxical intention and other. By drug formulation they are
segmented as capsules, tablet and others. On the basis of type of disease they
are poor quality of sleep, sleep maintenance and other.
Regional Analysis :
On regional basis, Europe accounts for accounts the largest
share in the Europe, the Middle East and Africa insomnia market. France
accounts for the largest market share in insomnia market in Europe. Middle East
is the second largest market for insomnia followed by Africa. Increase in prevalence of insomnia, thus
resulting in increasing consumption of sleeping pills is the major driving
factor for the market in Europe, the Middle East and Africa region.
Comments
Post a Comment